About Shasqi

Shasqi is a privately held, clinical stage biotechnology company whose mission is to enable patients to beat cancer without poisoning their bodies. Shasqi leverages its proprietary Click Activated Protodrugs Against Cancer (CAPAC™) Platform to develop precision activated oncology therapeutics designed to improve efficacy while decreasing systemic toxicity. Shasqi’s CAPAC Platform is highly modular and can be applied to a broad range of drugs that are otherwise limited by toxicity, enabling the exploration of therapeutic biology in ways that were not previously possible.

Shasqi and CAPAC™ Origins

Shasqi

Definition: \'shas-kē\ Noun. [fr. Quechua, ca. 1400‘s, also Chasqui, Chaski]

1. Hist. System of agile runners created to communicate and distribute goods across large distances. One of the components that enabled the rise of a vast Incan Empire.

2. A way to activate cancer drugs at specific areas of the body.

CAPAC

Definition: \'qhapaq’\ Noun. [fr. Quechua, ca. 1400‘s, also qhapaq]

1. Mighty, powerful, noble.

2. Click Activated Protodrugs Against Cancer (CAPAC™). A new platform to improve cancer therapies.

Leadership

José M. Mejía Oneto, MD, PhD

Founder & Chief Executive Officer

Wayne Saville, MD

Chief Medical Officer

Sebastian Sanchez de Lozada

Chief Financial Officer

Board of Directors

José M. Mejía Oneto, MD, PhD

Juan Jaen, PhD